Suven advances on securing three product patents in Canada, Europe and Hong Kong

09 Sep 2016 Evaluate

Suven Life Sciences is currently trading at Rs. 201.85, up by 5.65 points or 2.88% from its previous closing of Rs. 196.20 on the BSE.

The scrip opened at Rs. 197.45 and has touched a high and low of Rs. 205.10 and Rs. 196.20 respectively. So far 1,20,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 308.70 on 05-Oct-2015 and a 52 week low of Rs. 144.35 on 19-Feb-2016.

Last one week high and low of the scrip stood at Rs. 205.10 and Rs. 188.60 respectively. The current market cap of the company is Rs. 2,569.20 crore.

The promoters holding in the company stood at 60.00%, while Institutions and Non-Institutions held 7.62% and 32.38% respectively.

Suven Life Sciences (Suven) has been granted one product patent from Canada, one product patent from Europe and one product patent from Hong Kong corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2030, 2032 and 2032 respectively.

The granted claims of the patents are from the mechanism of action include the class of selective 5-HT4 compounds and H3 Inverse agonist compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Major Depressive disorder (MDD), Parkinson and Schizophrenia.

With these new patents, Suven has a total of twenty four granted patents from Canada, twenty two granted patents from Europe and twenty one granted patents from Hong Kong. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II.


Suven Life Sciences Share Price

167.20 -1.25 (-0.74%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×